Immune thrombocytopenia (ITP)
- Treat bleeding risk—not platelet count alone
- Steroid or IVIG for significant newly diagnosed disease
- Severe bleeding → IVIG + steroid + platelet support
- Persistent disease: TPO agonist, rituximab or splenectomy
- Avoid unnecessary platelet transfusion without bleeding
- Review drugs/infections and secondary causes
Use at a glance
- Treat bleeding risk—not platelet count alone
Treatment options
- Persistent disease: TPO agonist, rituximab or splenectomy
- Review drugs/infections and secondary causes
Other treatment options
- Steroid or IVIG for significant newly diagnosed disease
Safety / pitfalls
- Severe bleeding → IVIG + steroid + platelet support
- Avoid unnecessary platelet transfusion without bleeding
Self-check
- What should be treated in Immune thrombocytopenia (ITP)?
bleeding risk—not platelet count alone.
- What should generally be avoided in Immune thrombocytopenia (ITP)?
unnecessary platelet transfusion without.
Drugs used for this (2)
All clinical uses · Open the interactive console ↗
